General Hospital Medicine   

Would you be comfortable with the use of DOACs?

In other words, are there benefits to identifying URI pathogens that do not necessarily have targeted therapies (e.g., rhinovirus, non-COVID-19 Corona...

Do you extend the course of fidaxomicin past initial 10 days to at least 3-7 days after completion of antibiotics?

For example, do you find trending WBC, procalcitonin, CRP, etc., more or less helpful?